{
    "Trade/Device Name(s)": [
        "Xprecia Stride\u2122 Coagulation System",
        "Xprecia\u2122 System PT Controls"
    ],
    "Submitter Information": "Siemens Healthcare Diagnostics, Inc.",
    "510(k) Number": "K151964",
    "Predicate Device Reference 510(k) Number(s)": [
        "K060978"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "GJS",
        "GGN"
    ],
    "Summary Letter Date": "September 26, 2016",
    "Summary Letter Received Date": "September 27, 2016",
    "Submission Date": "September 30, 2016",
    "Regulation Number(s)": [
        "21 CFR 864.7750",
        "21 CFR 864.5425"
    ],
    "Regulation Name(s)": [
        "Prothrombin time test",
        "Plasma, coagulation control"
    ],
    "Analyte Class(es)": [
        "coagulation"
    ],
    "Analyte(s)": [
        "Prothrombin time (PT)",
        "International Normalized Ratio (INR)"
    ],
    "Specimen Type(s)": [
        "Capillary (fingerstick) whole blood",
        "Lyophilized human plasma (controls)"
    ],
    "Specimen Container(s)": [
        "Single-use PT/INR test strips",
        "Control vials"
    ],
    "Instrument(s)/Platform(s)": [
        "Xprecia Stride\u2122 Coagulation Analyzer"
    ],
    "Method(s)/Technology(ies)": [
        "Electrochemical technology",
        "Amperometric (electric current) detection of thrombin activity"
    ],
    "Methodologies": [
        "Prothrombin time testing",
        "INR calculation"
    ],
    "Submission Type(s)": [
        "Analyzer",
        "Test Strip",
        "Control",
        "Reagent"
    ],
    "Document Summary": "FDA 510(k) summary for Siemens Xprecia Stride\u2122 Coagulation System and PT Controls for point-of-care prothrombin time/INR measurement using electrochemical detection",
    "Indications for Use Summary": "Intended for point-of-care professional use by healthcare providers for monitoring oral anticoagulation therapy (warfarin) in stabilized patients (18+ years, >6 weeks on warfarin); uses capillary whole blood to determine INR via prothrombin time.",
    "fda_folder": "Hematology"
}